Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SyntheticMR’s quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed to support shorter scan times

SyntheticMR announced today that their product SyMRI NEURO and Philips SmartSpeed can now be combined. The powerful combination of AI with Philips SmartSpeed and SyntheticMR’s quantitative imaging solution can provide multiple contrast images, tissue segmentations and volumetric data in less than three minutes.SyntheticMR, an innovative software solutions company for MRI announced today the combination between their product SyMRI NEURO and Philips SmartSpeed. The joint offering will enable users of Philips scanners to do a complete MRI scan of the brain in less than three minutes* while

WithSecure™ bringing intelligence-driven protection to defenders with creation of new unit

WithSecure Intelligence’s unique blend of threat research and machine learning expertise is expected to prove vital in the fight against emerging threats.Helsinki, Finland – July 13, 2022: The world's increasingly fraught geopolitical situation has precipitated a concerning variety of cyber attacks targeting individuals, corporations, civil infrastructure, and governments. These threats have become progressively abundant and sophisticated in nature, leading WithSecure ™ (formerly known as F-Secure Business) to create a new unit to help combat these adversaries.

Interim report Q2 2022

Second quarter 2022 ● Incoming orders rose 23% to SEK 1,295 million (1,057) ● Net sales rose 23% to SEK 1,191 million (968) ● Operating profit rose 31% to SEK 201 million (153) ● EBITA rose 33% to SEK 208 million (156) ● Profit after tax rose 31% to SEK 156 million (119) ● Earnings per share were SEK 1.13 (0.86) January - June 2022 ● Incoming orders rose 25% to SEK 2,589 million (2,074) ● Net sales rose 23% to SEK 2,309 million (1,875) ● Operating profit rose 32% to SEK 382 million (288) ● EBITA rose 34% to SEK 394 million (295) ● Profit after tax rose 33%

Salsa Launches END 2 END Bingo Products on its Aggregator

Salsa Technology  has enhanced its online casino offering with the launch of END 2 END’s premium Multiplayer Bingo solution.END 2 END’s pioneering Bingo offering is now available on Salsa’s aggregator platform and partners will be able to gain access to a wide selection of 90 and 75 ball bingo solutions and lottery games.  Following the launch, Salsa now has one of the most renowned Multiplayer Bingo technologies available, while enabling it to provide a variety of real-time Bingo games in different modalities that spans Online, Retail and Live. Salsa

InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe

July 13, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European Patent Office (EPO). The patent provides additional protection for the use of cobitolimod in the treatment of inflammatory bowel disease.The patent, with patent number 3947685, will provide an exclusivity period until August 2040, with the possibility of up to 5 years term extension after market approval. “We are very pleased that the patent has been granted by the European Patent Office, which again confirms that

Visma delivers all-time high revenue and sharpens software focus

Visma grew its revenues by 16 percent to a record EUR 602 million in Q2. The announced divestment of the Group’s IT consulting business will further accelerate Visma’s strategy as a leading provider of cloud software in Europe. Visma continued its strong development in the second quarter, with revenue reaching an all-time high of EUR 602 million, a growth of 16 percent compared to EUR 520 million in the same period last year. EBITDA grew 6 percent to EUR 148 million (140). Despite heightened uncertainty about global economic prospects, Visma’s core markets remain strong. Both the

Invitation to Medicover’s results presentation for Q2 2022

Medicover’s (MCOV B ) Q2 report 2022 will be published on 22 July at 07.45 CEST. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST. The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session. Shortly before the webcast, presentation slides will be available on medicover.com . To access live webcast register here . To dial in

Truecaller launches the new voice-based app Open Doors – which enables conversations between people globally

Truecaller, the world’s leading global communications platform, today launched a brand-new app for safe, secure and private audio conversations: Open Doors. The app is a result of a dedicated development work from teams in Stockholm and India. After building Truecaller that safeguards people in their digital lives, and the free app Guardians for personal safety, Open Doors is now setting eyes on a new target: enabling fun, impromptu, global private conversations. Open Doors will be completely free to use and available globally on the Google Play Store & Apple App Store. The app

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 123 - 13 JULY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 117/2022.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

Clas Ohlson’s Annual and Sustainability Report for 2021/22 now available

Clas Ohlson’s integrated annual report for 2021/22 is now available at about.clasohlson.com. The Annual and Sustainability Report is a summary of the past year with examples of how the company’s strategy is put into practice and follows up on previously communicated financial and sustainability goals. The report also contains both standard and specific disclosures on sustainability aspects based on the GRI Standards. The scope is described in the GRI index in the report. The Annual and Sustainability Report is available in both Swedish and English versions. This year’s report

Scandinavian ChemoTech announces the receival of ethics committee approval for a clinical trial with the TSE™ technology at ‘All India Institute of Medical Sciences’ (AIIMS) in India

ChemoTech’s newly started Centre of Excellence (CoE) at the India Sweden Healthcare Innovation Centre at AIIMS in Jodhpur, in India has progressed into an initial approval for its Ethical committee for Head & Neck cancer.AIIMS, Jodhpur in India has received the Ethical Approval for “A clinical applicability study of the tumour specific electroporation technique for patients with locally advanced or recurrent head & neck cancer using IQwave 3.0 CE”.    The Investigator-Initiated Trial (IIT) was presented to the Ethical board by the Principal Investigator Dr. Jeewan Ram Vishnoi,

Proposal for new board member in Scandi Standard

Further to a proposal from the Nomination Committee, the Board of Directors of Scandi Standard AB (publ) has resolved that an Extraordinary General Meeting (EGM) shall be held by mid-August 2022 for the purpose of electing Paulo Gaspar as new board member. Paulo Gaspar represents Lusiaves Group, who has recently become the second largest shareholder of Scandi Standard.The board of directors of Scandi Standard will convene an extraordinary general meeting to address the nomination committee’s proposals in the near future. The notice of the extraordinary general meeting will be published by

Rejlers wins new agreement with Telenor

Rejlers Norway has been commissioned to assist Telenor in connection with the development of the 5G network in Norway. The agreement runs for three years and includes verification of documentation carried out by contractors for Telenor.Rejlers has collaborated with both Telenor Norway and Telenor Infra for many years and is now gaining renewed confidence through the new agreement. "We are very pleased that the good cooperation continues regarding the verification of documentation. Rejlers has solid expertise and extensive experience in developing both mobile and fiber networks," says

Doubled profitability and continued strong growth

Second Quarter (April–June 2022) Net sales amounted to TSEK 106,392 (79,885), which is an increase of 33.2% compared to the same period last year. The gross margin amounted to 58.6% (54.5). Operating profit before depreciation and amortization (EBITDA) amounted to TSEK 29,911 (16,422), which corresponds to an operating margin before depreciation and amortization of 28.1% (20.6). Operating profit (EBIT) amounted to TSEK 20,589 (9,960), which corresponds to an operating margin of 19.4% (12.5). Earnings per share before dilution amounted to SEK 1.48 (0.72). (Comparative

ChloraSolv is available in the UK through NHS Supply Chain

As of 11[th] of July 2022, ChloraSolv is available in the UK to NHS (National Health Service) organizations who purchase from NHS Supply Chain or directly from ConvaTec. ChloraSolv is available to all NHS facilities who have an account at NHS Supply Chain. It is applicable to a range of settings, including hospitals as well as primary and home care settings. ChloraSolv also can be purchased directly from ConvaTec, RLS' exclusive distribution partner for ChloraSolv in Europe.ChloraSolv’s inclusion on the NHS Supply Chain advanced wound care framework is the first step to enabling access to

Tokmanni Group Corporation will publish its half-year financial report on 29 July 2022

Tokmanni Group Corporation        Investor news        13 July 2022 at 9:30 amTokmanni will publish its half-year financial report on 29 July 2022 at approximately 8:30 am (Finnish time). The stock exchange release and the presentation materials in Finnish and in English will be available on the company's website at https://ir.tokmanni.fi/en/investors as soon as possible after the publication of the report. Tokmanni’s President and CEO Mika Rautiainen and CFO Markku Pirskanen will present the review to analysts, investors and media representatives on the publication day at 11:30 am in

Konecranes successfully places €300 million ESG-linked Schuldschein loan on strong demand from investors

KONECRANES PLC PRESS RELEASE July 13, 2022 at 9:30 EEST   Konecranes successfully places €300 million ESG-linked Schuldschein loan on strong demand from investors   Konecranes has successfully issued a Schuldschein loan, raising a total of €300 million. The sustainability-linked loan has floating and fixed rate tranches with maturities until 2026, 2027 and 2030. The interest margin will be adjusted based on Konecranes’ EcoVadis ESG rating, currently ‘Gold’, and the company will seek to further improve its ESG performance through the execution of its sustainability strategy.

RhoVac terminates its stock liquidity provision service and announces the last day for trading in the convertible

RhoVac AB ("RhoVac"), announces today that the company with effect from 13 July has terminated its agreement with Sedermera on a liquidity provision service for the company's stock. The first trading day without a liquidity provision will be July 14, 2022. Furthermore, the company announces that the last day for trading in the company's convertible is July 13, 2022.Pending a final decision regarding the company's future, RhoVac has decided to terminate the agreement with Sedermera regarding stock liquidity provision. In practice, the liquidity provision means a guaranteed available volume

Acting CEO of Balco Group AB

Växjö July 13, 2022The board of directors of Balco Group AB (publ) has decided to appoint Camilla Ekdahl, currently COO and Managing Director of Balco AB, as acting President and CEO of Balco Group from 1 September 2022 until the recruitment process is completed. As previously communicated, Kenneth Lundahl has decided to leave his role as President and CEO. He will remain in service until September 1 and will then be available to the company during his notice period until mid-December.

HKScan publishes its Half Year Financial Report on 20 July 2022

HKScan Corporation, media release 13 July 2022HKScan Corporation publishes its January-June Half Year Financial Report on Wednesday 20 July 2022 at about 8.30 a.m. EET. CEO Tero Hemmilä’s video review will be available at www.hkscan.com . Investor calls will be arranged upon requests. Kindly contact Heidi Hirvonen, heidi.hirvonen@hkscan.com or tel. +358 10 570 6072 to make an appointment. HKScan Corporation Heidi HirvonenSVP Communications  For further information:HKScan Media Service Desk tel. +358 10 570 5700 or email communications@hkscan.com

Asetek SimSports™ and Hardpoint to Bring Invicta™ Pedals in Sim Rigs to IMSA Endurance Races and Hardpoint Race Shop

Aalborg, Denmark – July 13, 2022 – Asetek, sim racing gear innovator, and sports car championship-winning and esports leader Hardpoint announced an agreement whereby Asetek SimSports™ racing products will be available to try out in sim rigs at International Motor Sports Association (IMSA) endurance race events and will be available to try and purchase in the Hardpoint race shop. As part of the agreement, and as an official sponsor of the Hardpoint esports team, Asetek SimSports™ branding will be prominent during iRacing events. “What André and the Asetek team have done is uncanny, and

Remedy Entertainment Plc: Publishing time for half year 2022 report

Remedy Entertainment Plc | Press Release 09:00 a.m. (EEST) July 13, 2022 Publishing time for half year 2022 report Remedy Entertainment Plc will publish its half year 2022 report on Friday August 12, 2022 at 9:00 a.m. (EEST). Remedy will host a webcast and conference call in English on its half year 2022 financial results for investors, analysts and media on Friday August 12, 2022, at 2:00 p.m. (EEST). Remedy’s half year report will be presented by CEO Tero Virtala and CFO Terhi Kauppi. The half year report will be available after publication on Remedy’s Investor Relations

There are no items matching the current filter
There are no more items matching the current filter
Back to top